Establishment Labs (ESTA)
(Delayed Data from NSDQ)
$45.25 USD
+3.43 (8.20%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $45.27 +0.02 (0.04%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$45.25 USD
+3.43 (8.20%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $45.27 +0.02 (0.04%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum F VGM
Zacks News
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -55.10% and 1.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GoodRx Holdings, Inc. (GDRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
GoodRx Holdings, Inc. (GDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -114.29% and 8.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Biodesix, Inc. (BDSX) delivered earnings and revenue surprises of 14.89% and 28.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 38.03% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 42.86% and 8.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for January 13th
by Zacks Equity Research
CP, HALO, AMX, ESTA, and GEO have been added to the Zacks Rank #5 (Strong Sell) List on January 13, 2021.
New Strong Sell Stocks for January 12th
by Zacks Equity Research
ASH, CAH, and ESTA have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2022
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -79.41% and 5.60%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 21.43% and 1.57%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Here's What Could Help Establishment Labs Holdings Inc. (ESTA) Maintain Its Recent Price Strength
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 9.38% and 20.38%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Establishment Labs Holdings Inc. (ESTA) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -35.29% and -0.14%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Establishment Labs' (ESTA) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Establishment Labs Holdings (ESTA).
Establishment Labs (ESTA) Catches Eye: Stock Jumps 5.7%
by Zacks Equity Research
Establishment Labs (ESTA) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Earnings Preview: Establishment Labs Holdings Inc. (ESTA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc's (TDOC) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Teladoc's (TDOC) first-quarter earnings gain from higher revenues, partly offset by a rise in expenses.
Will Establishment Labs Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Establishment Labs
Medical Services Outlook Bright Amid Coronavirus Crisis
by Urmimala Biswas
Despite the coronavirus-led worldwide sales disruption, medical services is one of the few sectors witnessing industry-wide growth right now.
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -19.23% and 14.27%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 15.38% and 7.88%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?